论文部分内容阅读
目的 We conducted this retrospective study to investigate whether microwave ablation(MWA)of primary tumor sites plus epidermal growth factor receptor-tyrosine kinase inhibitors(EGFR-TKIs)could improve survival in advanced non small cell lung cancer(NSCLC)with EGFR mutations 方法 MWA was conducted at the primary tumor sites,followed by EGFR-TKIs in the MWA plus EGFR-TKIs group.